Diagnostic Product Development

PBI’s collaborations with diagnostic manufacturers allows PBI to offer cutting edge technology and first access to many novel biomarkers.

• Extensive experience in lipids, cardiovascular risk, diabetes, metabolic syndrome, osteoporosis, and cartilage metabolism.
• Development and validation of reagents and new methods
• Extensive experience in the support of FDA 510(k) submissions